Composite inpatient healthcare supply may retain exemption despite MRP medicine billing, while separate taxable sale characterisation remains disputed...
Working-capital adjustment determines whether software-services transfer-pricing margins fall within the statutory tolerance range, eliminating any ad...
Permanent establishment deductions upheld for expatriate salaries, direct costs and trading losses, while head-office costs require fresh classificati...
The AAR held that the three diagnostic test kits are properly classifiable under HSN 3002 rather than HSN 3822, applying the principle affirmed by the SC in analogous precedent. Consequently, the applicant's goods do not fall within the residual chemical preparations heading and are taxable as instruments/reagents for diagnostic purposes. The applicant is directed to discharge GST at the concessional rate of 5% under Schedule I, Sr. No. 180. The ruling determines classification and tax liability prospectively for the applicant, subject to statutory compliance and any rights of appeal available under the governing indirect tax jurisprudence.
The AAR held that the three diagnostic test kits are properly classifiable under HSN 3002 rather than HSN 3822, applying the principle affirmed by the SC in analogous precedent. Consequently, the applicant's goods do not fall within the residual chemical preparations heading and are taxable as instruments/reagents for diagnostic purposes. The applicant is directed to discharge GST at the concessional rate of 5% under Schedule I, Sr. No. 180. The ruling determines classification and tax liability prospectively for the applicant, subject to statutory compliance and any rights of appeal available under the governing indirect tax jurisprudence.
Note: It is a system-generated summary and is for quick reference only.